GLP-1 benefits: new data confirms what employees want 

Purple injectable GLP-1s lay beside a purple weight sclae.

National survey findings suggest that employers must consider much more than just coverage of medication to achieve successful, sustainable weight loss benefits design. The right strategy integrates clinical guidance, behavioral health support and ongoing monitoring and outcomes measurement.

Integrated obesity management: The missing piece in GLP-1 coverage conversations

red background with a white head puzzle piece with one yellow lightbulb in the upper left

GLP-1 medications have quickly taken center stage when it comes to talking about obesity care. As demand grows, employers now have to navigate complex decisions around access, cost, and long-term sustainability, often with increasing financial and regulatory demands. As coverage conversations continue to amp up the pressure, it’s easy to default to a focus only […]

Whole-person health: Employee benefits that go beyond the scale

Scale symbolizing weight loss, with focus on health benefits beyond the number on the scale.

When we talk about health, it’s easy to default to the metrics, including weight, BMI, steps, blood pressure, blood sugar. These metrics matter. They help us understand risk, measure progress, and quantify outcomes for employers and health plans. But they don’t tell the full story. They don’t reflect the extra energy someone has at the […]

Building a scalable, future-ready GLP-1 strategy for employers

Discover how employers can build scalable, sustainable GLP-1 strategies that balance access, outcomes, and cost control amid changing pricing and utilization trends. As conversations about lowering GLP‑1 costs continue to dominate the benefits landscape, optimism is growing. Self-pay pricing agreements and the emergence of oral GLP-1 medications are expected to expand access for individuals. For […]

My next decade in healthcare: Focusing on what matters most  

After three decades in healthcare, I have seen firsthand that we are solving the wrong problem and treating chronic high-cost conditions instead of preventing them.  My background is in business development, but I’ve worked across a wide range of settings, from pharmaceuticals to hospitals, ICUs, palliative care, hospice, skilled nursing facilities, and digital health. In every role, I saw […]

Take a breath: How employers can navigate new GLP-1 pricing

While the latest GLP-1 pricing headlines offer hope for individuals looking to access these medications at a lower cost, they raise concerns for employers and payers who must navigate utilization, coverage gaps, and budget implications.    GLP-1 costs may appear more predictable under the the latest most-favored-nation (MFN) pricing deals. However, the ‘$149 a month’ headlines may create a false […]

Empathy in Action: Insights from Wondr Health’s Robin Patton

After 17 years at Wondr Health, Sr. Director of Coaching and Clinical Operations Robin Patton has seen thousands of lives transform—not just through weight loss, but through the deeper behavioral shifts that ripple through families and workplaces. As a licensed social worker and long-time leader, she brings a rare mix of heart and science to […]

Scouting the Future: Building a Championship-Caliber Benefits Strategy

The demand for GLP-1 medications keeps climbing—and so do the costs. As the benefits landscape continues to shift, weight management has become one of the most challenging areas to get right. GLP-1s have redefined what’s possible for metabolic health—but they’ve also introduced new pressures for employers trying to balance impact and affordability. For employers it’s […]